BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 15567848)

  • 1. Common and distinct elements in cellular signaling via EGF and FGF receptors.
    Schlessinger J
    Science; 2004 Nov; 306(5701):1506-7. PubMed ID: 15567848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heparan sulfate proteoglycans function as receptors for fibroblast growth factor-2 activation of extracellular signal-regulated kinases 1 and 2.
    Chua CC; Rahimi N; Forsten-Williams K; Nugent MA
    Circ Res; 2004 Feb; 94(3):316-23. PubMed ID: 14684627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidermal growth factor receptors containing a single tyrosine in their C-terminal tail bind different effector molecules and are signaling-competent.
    Gill K; Macdonald-Obermann JL; Pike LJ
    J Biol Chem; 2017 Dec; 292(50):20744-20755. PubMed ID: 29074618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential tyrosine phosphorylation of fibroblast growth factor (FGF) receptor-1 and receptor proximal signal transduction in response to FGF-2 and heparin.
    Lundin L; Rönnstrand L; Cross M; Hellberg C; Lindahl U; Claesson-Welsh L
    Exp Cell Res; 2003 Jul; 287(1):190-8. PubMed ID: 12799194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kinetic model for FGF, FGFR, and proteoglycan signal transduction complex assembly.
    Ibrahimi OA; Zhang F; Hrstka SC; Mohammadi M; Linhardt RJ
    Biochemistry; 2004 Apr; 43(16):4724-30. PubMed ID: 15096041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A reaction-diffusion model of basic fibroblast growth factor interactions with cell surface receptors.
    Filion RJ; Popel AS
    Ann Biomed Eng; 2004 May; 32(5):645-63. PubMed ID: 15171620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Signal transduction by fibroblast growth factor receptors.
    Klint P; Claesson-Welsh L
    Front Biosci; 1999 Feb; 4():D165-77. PubMed ID: 9989949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Signaling, internalization, and intracellular activity of fibroblast growth factor.
    Wiedłocha A; Sørensen V
    Curr Top Microbiol Immunol; 2004; 286():45-79. PubMed ID: 15645710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel type I fibroblast growth factor receptor activates mitogenic signaling in the absence of detectable tyrosine phosphorylation of FRS2.
    Lopez ME; Korc M
    J Biol Chem; 2000 May; 275(21):15933-9. PubMed ID: 10748122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specific inhibition of FGF-induced MAPK activation by the receptor-like protein tyrosine phosphatase LAR.
    Wang X; Weng LP; Yu Q
    Oncogene; 2000 May; 19(19):2346-53. PubMed ID: 10822386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Requirement for anticoagulant heparan sulfate in the fibroblast growth factor receptor complex.
    McKeehan WL; Wu X; Kan M
    J Biol Chem; 1999 Jul; 274(31):21511-4. PubMed ID: 10419453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential activation of epidermal growth factor (EGF) receptor downstream signaling pathways by betacellulin and EGF.
    Saito T; Okada S; Ohshima K; Yamada E; Sato M; Uehara Y; Shimizu H; Pessin JE; Mori M
    Endocrinology; 2004 Sep; 145(9):4232-43. PubMed ID: 15192046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EGFR and FGFR signaling through FRS2 is subject to negative feedback control by ERK1/2.
    Wu Y; Chen Z; Ullrich A
    Biol Chem; 2003 Aug; 384(8):1215-26. PubMed ID: 12974390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two hierarchies of FGF-2 signaling in heparin: mitogenic stimulation and high-affinity binding/receptor transphosphorylation.
    Krufka A; Guimond S; Rapraeger AC
    Biochemistry; 1996 Aug; 35(34):11131-41. PubMed ID: 8780517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibroblast growth factor (FGF) and FGF receptor-mediated autocrine signaling in non-small-cell lung cancer cells.
    Marek L; Ware KE; Fritzsche A; Hercule P; Helton WR; Smith JE; McDermott LA; Coldren CD; Nemenoff RA; Merrick DT; Helfrich BA; Bunn PA; Heasley LE
    Mol Pharmacol; 2009 Jan; 75(1):196-207. PubMed ID: 18849352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth hormone-induced phosphorylation of epidermal growth factor (EGF) receptor in 3T3-F442A cells. Modulation of EGF-induced trafficking and signaling.
    Huang Y; Kim SO; Jiang J; Frank SJ
    J Biol Chem; 2003 May; 278(21):18902-13. PubMed ID: 12642595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacologically targeting the myristoylation of the scaffold protein FRS2α inhibits FGF/FGFR-mediated oncogenic signaling and tumor progression.
    Li Q; Alsaidan OA; Ma Y; Kim S; Liu J; Albers T; Liu K; Beharry Z; Zhao S; Wang F; Lebedyeva I; Cai H
    J Biol Chem; 2018 Apr; 293(17):6434-6448. PubMed ID: 29540482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Herstatin, an autoinhibitor of the human epidermal growth factor receptor 2 tyrosine kinase, modulates epidermal growth factor signaling pathways resulting in growth arrest.
    Justman QA; Clinton GM
    J Biol Chem; 2002 Jun; 277(23):20618-24. PubMed ID: 11934884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heparan sulfate fibroblast growth factor receptor complex: structure-function relationships.
    McKeehan WL; Kan M
    Mol Reprod Dev; 1994 Sep; 39(1):69-81; discusison 81-2. PubMed ID: 7999363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ligand regulates epidermal growth factor receptor kinase specificity: activation increases preference for GAB1 and SHC versus autophosphorylation sites.
    Fan YX; Wong L; Deb TB; Johnson GR
    J Biol Chem; 2004 Sep; 279(37):38143-50. PubMed ID: 15231819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.